Compare Repligen Corporation Common Stock (RGEN) vs Stitch Fix Inc (SFIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Stitch Fix Inc — how do they compare? Repligen Corporation Common Stock trades at $178.19 (market cap $11.14B), while Stitch Fix Inc trades at $2.38 (market cap $326.66M). The key difference: Repligen Corporation Common Stock is far larger — about 34.1× Stitch Fix Inc's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Stitch Fix Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Stitch Fix Inc for 31 Days on average.
| RGEN | SFIX | |
|---|---|---|
Market Cap | $11.14B | $326.66M |
Volume | 1,259,263 | 3,004,657 |
Sector | Health | Consumer Cyclical |
52-Week High | $194.57 | $5.64 |
52-Week Low | $102.87 | $2.16 |
Typical Hold Time | 0 Days | 31 Days |
Enterprise Value | $11.02B | $222.46M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Stitch Fix (SFIX) trades at $2.39, down 11.48% amid bearish technical signals and negative cash flow trends. The company shows improving fundamentals with three consecutive quarterly EPS beats and narrowing losses, though revenue remains stagnant at $1.27B. Recent news highlights fraud investigations and disappointing Q4 2026 results that missed revenue estimates, driving the stock's decline.
The outlook remains challenging with analyst consensus leaning neutral (69.7% hold) and a $3.40 price target suggesting limited upside. Key risks include ongoing legal scrutiny, weak FY27 guidance, and persistent net losses despite margin improvements. The stock's trajectory depends on reversing active client declines and achieving sustainable profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →
